Tara I Chang

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. pmc Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Stanford, California and
    Clin J Am Soc Nephrol 11:1401-12. 2016
  2. pmc Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis
    Tara I Chang
    Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanford, California Electronic address
    J Am Coll Cardiol 67:1459-69. 2016
  3. pmc Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial
    Tara I Chang
    From the Division of Nephrology T I C, R S, G M C and Stanford Prevention Research Center R S S, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA Departments of Biostatistical Sciences G E and Internal Medicine D K, Wake Forest School of Medicine, Winston Salem, NC Division of Nephrology and Hypertension, University of Utah, Salt Lake City A K C Medical Service, Memphis Veterans Affairs Medical Center, TN W C C Department of Medicine, The Medical College of Georgia, Georgia Regents University, Augusta M J D Division of Nephrology and Hypertension, Department of Medicine J P D and Department of General Internal Medicine and Public Health C L R, Vanderbilt University, Nashville, TN Renal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia Y H Departments of Medicine and Pharmacology, Robert Wood Johnson Medical School, New Brunswick, NJ J B K Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham S O Department of Medicine, University of California, Los Angeles A R VA Tennessee Valley Healthcare System Geriatrics Research and Education Clinical Center GRECC, Nashville C L R Medical Care Line, Michael E DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX A A T and Department of Medicine, Case Western Reserve University, Cleveland, OH J T W
    Hypertension 67:550-5. 2016
  4. pmc Coronary artery bypass graft type and outcomes in maintenance dialysis
    D Shilane
    Department of Health Research and Policy, Stanford University School of Medicine Palo Alto, CA, USA
    J Cardiovasc Surg (Torino) 56:463-71. 2015
  5. pmc Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP)
    Tara I Chang
    Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Am J Kidney Dis 61:S4-11. 2013
  6. pmc Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD
    Tara I Chang
    Division of Nephrology, Department of Medicine, Stanford University, 780 Welch Road Suite 106, Palo Alto, CA 94304, USA
    J Am Soc Nephrol 23:2042-9. 2012
  7. pmc Use of secondary prevention medications among adults with reduced kidney function
    Tara I Chang
    Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California, USA
    Clin J Am Soc Nephrol 7:604-11. 2012
  8. pmc Updated comorbidity assessments and outcomes in prevalent hemodialysis patients
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA
    Hemodial Int 14:478-85. 2010
  9. pmc Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study
    T I Chang
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    J Hum Hypertens 25:98-105. 2011
  10. pmc Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Am Heart J 162:324-30. 2011

Detail Information

Publications38

  1. pmc Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Stanford, California and
    Clin J Am Soc Nephrol 11:1401-12. 2016
    ..Few studies have examined medication use during this critical period. We examined patterns of antihypertensive medication use from the four quarters before and eight quarters after incident ESRD treated with maintenance dialysis...
  2. pmc Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis
    Tara I Chang
    Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanford, California Electronic address
    J Am Coll Cardiol 67:1459-69. 2016
    ..Few studies have focused on patients with end-stage renal disease...
  3. pmc Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial
    Tara I Chang
    From the Division of Nephrology T I C, R S, G M C and Stanford Prevention Research Center R S S, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA Departments of Biostatistical Sciences G E and Internal Medicine D K, Wake Forest School of Medicine, Winston Salem, NC Division of Nephrology and Hypertension, University of Utah, Salt Lake City A K C Medical Service, Memphis Veterans Affairs Medical Center, TN W C C Department of Medicine, The Medical College of Georgia, Georgia Regents University, Augusta M J D Division of Nephrology and Hypertension, Department of Medicine J P D and Department of General Internal Medicine and Public Health C L R, Vanderbilt University, Nashville, TN Renal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia Y H Departments of Medicine and Pharmacology, Robert Wood Johnson Medical School, New Brunswick, NJ J B K Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham S O Department of Medicine, University of California, Los Angeles A R VA Tennessee Valley Healthcare System Geriatrics Research and Education Clinical Center GRECC, Nashville C L R Medical Care Line, Michael E DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX A A T and Department of Medicine, Case Western Reserve University, Cleveland, OH J T W
    Hypertension 67:550-5. 2016
    ....
  4. pmc Coronary artery bypass graft type and outcomes in maintenance dialysis
    D Shilane
    Department of Health Research and Policy, Stanford University School of Medicine Palo Alto, CA, USA
    J Cardiovasc Surg (Torino) 56:463-71. 2015
    ..We sought to compare the effectiveness of multivessel bypass grafting using IMA versus SVG in patients on maintenance dialysis in the United States...
  5. pmc Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP)
    Tara I Chang
    Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Am J Kidney Dis 61:S4-11. 2013
    ....
  6. pmc Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD
    Tara I Chang
    Division of Nephrology, Department of Medicine, Stanford University, 780 Welch Road Suite 106, Palo Alto, CA 94304, USA
    J Am Soc Nephrol 23:2042-9. 2012
    ..In the absence of data from randomized trials, these results suggest that CABG may be preferred over PCI for multivessel coronary revascularization in appropriately selected patients on maintenance dialysis...
  7. pmc Use of secondary prevention medications among adults with reduced kidney function
    Tara I Chang
    Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California, USA
    Clin J Am Soc Nephrol 7:604-11. 2012
    ....
  8. pmc Updated comorbidity assessments and outcomes in prevalent hemodialysis patients
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA
    Hemodial Int 14:478-85. 2010
    ..Updated assessments of comorbidity significantly strengthen the ability to predict death in patients on hemodialysis. Future studies in dialysis should invest the necessary resources to include repeated assessments of comorbidity...
  9. pmc Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study
    T I Chang
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    J Hum Hypertens 25:98-105. 2011
    ..Randomized clinical trials are needed to define optimal blood pressure targets in the haemodialysis population...
  10. pmc Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    Am Heart J 162:324-30. 2011
    ..Angiotensin-converting enzyme inhibitors (ACEIs) are recommended for patients on dialysis, but there are few data regarding their effectiveness in ESRD...
  11. pmc Systolic blood pressure and mortality in patients on hemodialysis
    Tara I Chang
    Palo Alto, CA 94304, USA
    Curr Hypertens Rep 13:362-9. 2011
    ....
  12. pmc Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease
    Tara I Chang
    aStanford University School of Medicine, StanfordbDivision of Research, Kaiser Permanente Northern California, OaklandcDepartments of Epidemiology, Biostatistics and Medicine, University of California, San Francisco, California, USA
    J Hypertens 34:244-52. 2016
    ....
  13. doi request reprint Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction
    Matthew D Solomon
    Division of Research, Kaiser Permanente Northern California, Oakland, California Stanford University School of Medicine, Stanford, California Electronic address
    J Am Coll Cardiol 63:2249-57. 2014
    ..This study sought to examine the effectiveness of clopidogrel in real-world, medically managed patients with unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI)...
  14. pmc Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data
    C Vaughan Tuohy
    Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA
    BMC Nephrol 17:16. 2016
    ..Sleep disordered breathing (SDB) such as sleep apnea is associated with cardiovascular disease in the general population. However, little is known about the cardiovascular risks of SDB in patients with end-stage renal disease (ESRD)...
  15. pmc Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study
    Mark A Hlatky
    Stanford University School of Medicine, Stanford, CA 94305, USA
    Ann Intern Med 158:727-34. 2013
    ..Randomized trials of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) suggest that patient characteristics modify the effect of treatment on mortality...
  16. pmc Intradialytic hypotension and vascular access thrombosis
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA 94304, USA
    J Am Soc Nephrol 22:1526-33. 2011
    ..These results underscore the importance of including vascular access patency in future studies of BP management in hemodialysis...
  17. doi request reprint Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex
    Wolfgang C Winkelmayer
    Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX Electronic address
    Am J Kidney Dis . 2017
    ..We exploited a natural experiment to compare outcomes of patients initiating HD therapy in facilities that predominantly (in ≥90% of their patients) used iron sucrose versus sodium ferric gluconate complex...
  18. pmc Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis
    Jennifer E Flythe
    Renal Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Kidney Dis 61:966-74. 2013
    ..Blood pressure is known to fluctuate widely during hemodialysis; however, little is known about the association between intradialytic blood pressure variability and outcomes...
  19. pmc Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP)
    Carmen A Peralta
    Department of Medicine, San Francisco VA Medical Center, San Francisco, California, USA
    Arch Intern Med 172:41-7. 2012
    ..Treatment of hypertension is difficult in chronic kidney disease (CKD), and blood pressure goals remain controversial. The association between each blood pressure component and end-stage renal disease (ESRD) risk is less well known...
  20. pmc Incremental prognostic information from kidney function in patients with new onset coronary heart disease
    Mark A Hlatky
    Stanford University School of Medicine, Stanford, CA Electronic address
    Am Heart J 167:86-92. 2014
    ..The extent to which estimated glomerular filtration rate (eGFR) adds information about prognosis among patients with coronary heart disease is uncertain...
  21. pmc Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease
    Tara I Chang
    Stanford University School of Medicine, Division of Nephrology, Stanford, CA
    Am Heart J 165:800-8, 808.e1-2. 2013
    ....
  22. pmc Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation
    Jenny I Shen
    Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA Division of Nephrology and Hypertension, Harbor UCLA Medical Center, Torrance, CA
    Am J Kidney Dis 66:677-88. 2015
    ..Our aim was to examine outcomes after warfarin therapy initiation, relative to no warfarin use, following incident AF in a large cohort of hemodialysis patients who had comprehensive prescription drug coverage through Medicare Part D...
  23. pmc Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Stanford, CA T I C, M E M R, G M C, W C W
    J Am Heart Assoc 3:e001356. 2014
    ....
  24. pmc Multivessel coronary revascularization and outcomes in kidney transplant recipients
    Colin R Lenihan
    Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA
    Transpl Int 26:1080-7. 2013
    ..In this analysis of kidney transplant recipients undergoing multivessel coronary revascularization, we found no difference between CABG and PCI in terms of survival or the composite of death and MI...
  25. ncbi request reprint Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis
    Jenny I Shen
    Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, 1000 W Carson St, C 1 Annex, Torrance, CA, USA Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA
    Nephrol Dial Transplant . 2016
    ..We investigated the association between ACEI/ARB use and CV outcomes in patients initiating PD...
  26. pmc Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study
    Wolfgang C Winkelmayer
    Section of Nephrology, Baylor College of Medicine, Houston, TX Division of Nephrology, Department of Medicine Stanford University School of Medicine, Palo Alto, CA Electronic address
    Am J Kidney Dis 66:106-13. 2015
    ..Adequately powered studies directly comparing hard clinical outcomes of darbepoetin alfa (DPO) versus epoetin alfa (EPO) in patients undergoing dialysis are lacking...
  27. pmc Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients
    Medha Airy
    Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    Nephrol Dial Transplant 30:2068-75. 2015
    ....
  28. doi request reprint Acute kidney injury after CABG versus PCI: an observational study using 2 cohorts
    Tara I Chang
    Stanford University School of Medicine, Stanford, California
    J Am Coll Cardiol 64:985-94. 2014
    ....
  29. pmc Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation
    Colin R Lenihan
    Divisions of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA
    Nephrol Dial Transplant 30:321-9. 2015
    ..92; 95% CI 0.83-1.02), death (HR = 0.92; 95% CI 0.82-1.02) and death-censored graft failure (HR = 0.90; 95% CI 0.76-1.08). Our study suggests the need for clinical trials of warfarin use in the kidney transplant population with AF. ..
  30. pmc Use and safety of heparin-free maintenance hemodialysis in the USA
    Jenny I Shen
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA, USA
    Nephrol Dial Transplant 28:1589-602. 2013
    ..We describe the determinants of heparin-free HD and its association with adverse outcomes using data from a national dialysis provider merged with Medicare claims...
  31. pmc Kidney function and long-term medication adherence after myocardial infarction in the elderly
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA
    Clin J Am Soc Nephrol 6:864-9. 2011
    ..The association of kidney function with long-term outpatient medication adherence in the elderly remains understudied...
  32. ncbi request reprint Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis
    Jenny I Shen
    Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, 1000 W Carson St, Box 406, Torrance, CA, 90509, USA
    J Nephrol . 2016
    ..In this observational cohort study, we compared the association of ARB vs. ACEI use on CV outcomes in patients initiating PD...
  33. pmc The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Ian M Kronish
    From the Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, NY I M K Department of Epidemiology A I L, P M and Division of Cardiology S O, University of Alabama at Birmingham Primary Care Division, Clement J Zablocki VA Medical Center, Milwaukee, WI J W Coordinating Center for Clinical Trials, The University of Texas School of Public Health, Houston B R D, L M S Department of Medicine, Tulane University School of Medicine, Department of Epidemiology, Tulane University School of Public Health, and Tropical Medicine, Research Division, Ochsner Health System M K W Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN W C C and Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA T I C
    Hypertension 68:39-45. 2016
    ..In conclusion, improving medication adherence may lower VVV of BP. However, VVV of BP is associated with cardiovascular outcomes independent of medication adherence. ..
  34. pmc Preoperative statin use and postoperative acute kidney injury
    Steven M Brunelli
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    Am J Med 125:1195-1204.e3. 2012
    ..The purpose of this study was to evaluate whether preoperative statin use is associated with a decreased risk of postoperative acute kidney injury...
  35. pmc Orthostatic changes in systolic blood pressure among SPRINT participants at baseline
    Raymond R Townsend
    Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Electronic address
    J Am Soc Hypertens 10:847-856. 2016
    ....
  36. pmc Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease
    Tara I Chang
    Stanford University School of Medicine, Stanford, CA, USA
    J Card Fail 19:176-82. 2013
    ..We examined whether initiation of β-blocker therapy was associated with better outcomes among patients with chronic kidney disease and newly diagnosed heart failure with left ventricular systolic dysfunction...
  37. pmc Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records
    Benjamin A Goldstein
    Quantitative Sciences Unit and, Divisions of Nephrology and, Cardiovascular Medicine, Department of Medicine, Stanford University, Palo Alto, California
    Clin J Am Soc Nephrol 9:82-91. 2014
    ..This study aimed to test whether assessment of acute changes during hemodialysis that are captured in electronic health records improved risk assessment...
  38. pmc Balancing the Evidence: How to Reconcile the Results of Observational Studies vs. Randomized Clinical Trials in Dialysis
    Jenny I Shen
    Department of Medicine, Division of Hypertension and Nephrology, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California
    Semin Dial 29:342-6. 2016
    ..Ultimately, dialysis care requires both well-designed, well-conducted observational studies and RCTs to move the field forward. ..